A detailed history of Smith Chas P & Associates Pa Cpas transactions in Medtronic PLC stock. As of the latest transaction made, Smith Chas P & Associates Pa Cpas holds 9,936 shares of MDT stock, worth $810,181. This represents 0.05% of its overall portfolio holdings.

Number of Shares
9,936
Previous 11,140 10.81%
Holding current value
$810,181
Previous $876,000 2.05%
% of portfolio
0.05%
Previous 0.05%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$76.84 - $91.03 $92,515 - $109,600
-1,204 Reduced 10.81%
9,936 $894,000
Q2 2024

Jul 29, 2024

SELL
$78.71 - $87.02 $223,693 - $247,310
-2,842 Reduced 20.33%
11,140 $876,000
Q1 2024

Apr 25, 2024

SELL
$82.84 - $88.09 $70,414 - $74,876
-850 Reduced 5.73%
13,982 $1.22 Million
Q4 2023

Feb 01, 2024

SELL
$69.43 - $83.43 $22.7 Million - $27.3 Million
-326,971 Reduced 95.66%
14,832 $1.22 Million
Q3 2023

Nov 02, 2023

SELL
$78.22 - $90.4 $286,598 - $331,225
-3,664 Reduced 1.06%
341,803 $26.8 Million
Q2 2023

Jul 31, 2023

BUY
$79.47 - $91.38 $647,521 - $744,564
8,148 Added 2.42%
345,467 $30.4 Million
Q1 2023

Apr 27, 2023

BUY
$76.72 - $87.58 $998,510 - $1.14 Million
13,015 Added 4.01%
337,319 $27.2 Million
Q4 2022

Jan 12, 2023

BUY
$76.18 - $87.74 $342,657 - $394,654
4,498 Added 1.41%
324,304 $25.2 Million
Q3 2022

Nov 22, 2022

BUY
$80.75 - $95.31 $1.12 Million - $1.33 Million
13,923 Added 4.55%
319,806 $25.8 Million
Q2 2022

Jul 15, 2022

BUY
$87.4 - $113.09 $1.4 Million - $1.81 Million
15,976 Added 5.51%
305,883 $27.5 Million
Q1 2022

May 12, 2022

BUY
$100.58 - $112.38 $5.48 Million - $6.13 Million
54,519 Added 23.16%
289,907 $32.2 Million
Q4 2021

Feb 07, 2022

BUY
$99.53 - $127.75 $727,663 - $933,980
7,311 Added 3.21%
235,388 $24.4 Million
Q3 2021

Oct 12, 2021

BUY
$122.75 - $135.17 $913,751 - $1.01 Million
7,444 Added 3.37%
228,077 $28.6 Million
Q2 2021

Jul 23, 2021

BUY
$118.19 - $131.5 $561,166 - $624,362
4,748 Added 2.2%
220,633 $27.4 Million
Q1 2021

May 11, 2021

BUY
$111.18 - $119.74 $937,914 - $1.01 Million
8,436 Added 4.07%
215,885 $25.5 Million
Q4 2020

Feb 10, 2021

BUY
$100.57 - $117.14 $376,131 - $438,103
3,740 Added 1.84%
207,449 $24.3 Million
Q3 2020

Nov 10, 2020

BUY
$90.13 - $108.78 $100,044 - $120,745
1,110 Added 0.55%
203,709 $21.2 Million
Q2 2020

Aug 13, 2020

BUY
$84.11 - $103.33 $131,632 - $161,711
1,565 Added 0.78%
202,599 $18.6 Million
Q1 2020

May 11, 2020

BUY
$72.92 - $121.3 $3.57 Million - $5.94 Million
48,954 Added 32.19%
201,034 $18.1 Million
Q4 2019

Feb 04, 2020

BUY
$104.49 - $114.54 $1.63 Million - $1.79 Million
15,627 Added 11.45%
152,080 $17.3 Million
Q3 2019

Nov 06, 2019

BUY
$98.02 - $111.18 $1.35 Million - $1.53 Million
13,748 Added 11.2%
136,453 $14.8 Million
Q2 2019

Aug 09, 2019

BUY
$84.15 - $99.38 $10.1 Million - $11.9 Million
120,100 Added 4610.36%
122,705 $12 Million
Q1 2019

May 08, 2019

BUY
$82.45 - $93.79 $214,782 - $244,322
2,605 New
2,605 $237,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Smith Chas P & Associates Pa Cpas Portfolio

Follow Smith Chas P & Associates Pa Cpas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Chas P & Associates Pa Cpas, based on Form 13F filings with the SEC.

News

Stay updated on Smith Chas P & Associates Pa Cpas with notifications on news.